STAT

The Readout Loud

Business EN ↓ 413 episodes

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Author

STAT

Episodes

Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen 24.05.2018 27:48

How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing? Listen this week to find out.

Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes 17.05.2018 22:45

What do you call a unicorn without a horn? Is your colleague wearing a wire? And is Jentadueto a drug name or a complicated espresso drink?

Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office? 10.05.2018 22:28

On today's show, we dig into the no good, very bad day Novartis had when the world got wind of its ties to President Trump's personal attorney, a discussion of how the world's biggest cancer conference used to be the Wild West for investors, and an exploration of one health system's plan to bring genomics to the masses. Also STAT's Eric Boodman joins us to talk about how a pricey new gene therapy...

Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics 03.05.2018 27:37

We talk to Bill Gates about the flu that could kill millions. Is China too enamored with biotech startups? And how do you find a cold case killer? Genetics.

Episode #8 - Megamergers, migraines, and biotech's Four Horsemen 26.04.2018 25:04

What's a good use of $64 billion? Is Big Biotech boring now? And what's the best way to sell hair restoration products to men?

Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism 19.04.2018 21:55

Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?

Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR 12.04.2018 23:33

Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?

Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr 05.04.2018 22:32

What's it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?

Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card 29.03.2018 23:36

Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book for the price tag of a medicine?

Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try? 22.03.2018 24:46

What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?

Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies 15.03.2018 21:41

Did Elizabeth Holmes get off easy? Why does biotech bother with SXSW? And what does shoving a tube into a dead cow’s throat have to do with biotech?

Episode #1 - Shkreli's sentence, biotech froth, and a blood party 08.03.2018 18:23

How long is Martin Shkreli going to be in prison? Is the biotech bubble about to burst? And what's it like to attend a blood-swapping gala? Listen to our first episode of, "The Readout LOUD."

Coming soon: "The Readout LOUD" 02.03.2018 1:15

An introduction to a new weekly biotech podcast from STAT.